Close

Ratings by William Blair (Brian Weinstein)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/15/2022 10X Genomics TXG Downgrade Market Perform
(Outperform)
43.29
(34.99)
-19.17% Details
7/7/2022 Meridian Biosciences VIVO Maintain Market Perform
(Outperform)
 
 
  Details
2/3/2022 Glaukos Corporation GKOS Upgrade Outperform
(Market Perform)
52.90
(45.62)
-13.76% Details
8/9/2021 Sera Prognostics Inc SERA New Coverage Outperform
(N/A)
12.89
(1.21)
-90.61% Details
7/14/2021 Glaukos Corporation GKOS Downgrade Market Perform
(Outperform)
77.00
(45.62)
-40.75% Details
5/4/2021 Lucira Health Inc. LHDX Downgrade Market Perform
(Outperform)
6.26
(0.40)
-93.61% Details
3/15/2021 10X Genomics TXG New Coverage Outperform
(N/A)
160.02
(34.99)
-78.13% Details
3/2/2021 Lucira Health Inc. LHDX New Coverage Outperform
(N/A)
19.39
(0.40)
-97.94% Details
1/12/2021 908 Devices Inc. MASS New Coverage Outperform
(N/A)
56.63
(9.92)
-82.48% Details
11/23/2020 Biodesix BDSX New Coverage Outperform
(N/A)
17.09
(1.36)
-92.04% Details
2/6/2020 Becton Dickinson BDX Maintain Outperform
(N/A)
 
 
  Details
11/21/2019 Hologic HOLX Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 AxoGen, Inc. AXGN Downgrade Market Perform
(Outperform)
17.58
(10.48)
-40.39% Details
7/22/2019 Adeptus Biotechnologies Corp. ADPT New Coverage Outperform
(N/A)
38.01
(7.86)
-79.32% Details
3/19/2019 Becton Dickinson BDX Maintain Outperform
(N/A)
 
 
  Details
10/29/2018 Guardant Health GH New Coverage Outperform
(N/A)
35.14
(49.50)
40.87% Details
9/11/2018 Invuity IVTY Downgrade Market Perform
(Outperform)
5.75
(7.39)
28.52% Details
8/29/2018 Glaukos Corporation GKOS Maintain Outperform
(N/A)
 
 
  Details